Literature DB >> 27054991

Genome editing for clinical HIV isolates.

Michelle Kim1, Robert F Siliciano1.   

Abstract

Mesh：

Year:  2016        PMID： 27054991     DOI： 10.1038/nbt.3531

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  11 in total

1.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  Alteration of Cre recombinase site specificity by substrate-linked protein evolution.

Authors:  F Buchholz; A F Stewart
Journal:  Nat Biotechnol       Date:  2001-11       Impact factor: 54.908

3.  HIV-1 proviral DNA excision using an evolved recombinase.

Authors:  Indrani Sarkar; Ilona Hauber; Joachim Hauber; Frank Buchholz
Journal:  Science       Date:  2007-06-29       Impact factor: 47.728

4.  Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity.

Authors:  Janet Karpinski; Ilona Hauber; Jan Chemnitz; Carola Schäfer; Maciej Paszkowski-Rogacz; Deboyoti Chakraborty; Niklas Beschorner; Helga Hofmann-Sieber; Ulrike C Lange; Adam Grundhoff; Karl Hackmann; Evelin Schrock; Josephine Abi-Ghanem; M Teresa Pisabarro; Vineeth Surendranath; Axel Schambach; Christoph Lindner; Jan van Lunzen; Joachim Hauber; Frank Buchholz
Journal:  Nat Biotechnol       Date:  2016-02-22       Impact factor: 54.908

5.  RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.

Authors:  Wenhui Hu; Rafal Kaminski; Fan Yang; Yonggang Zhang; Laura Cosentino; Fang Li; Biao Luo; David Alvarez-Carbonell; Yoelvis Garcia-Mesa; Jonathan Karn; Xianming Mo; Kamel Khalili
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

6.  Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

Authors:  Gero Hütter; Daniel Nowak; Maximilian Mossner; Susanne Ganepola; Arne Müssig; Kristina Allers; Thomas Schneider; Jörg Hofmann; Claudia Kücherer; Olga Blau; Igor W Blau; Wolf K Hofmann; Eckhard Thiel
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

7.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors:  Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

8.  Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells.

Authors:  Xiying Qu; Pengfei Wang; Donglin Ding; Lin Li; Haibo Wang; Li Ma; Xin Zhou; Shaohui Liu; Shiguan Lin; Xiaohui Wang; Gongmin Zhang; Sijie Liu; Lin Liu; Jianhua Wang; Feng Zhang; Daru Lu; Huanzhang Zhu
Journal:  Nucleic Acids Res       Date:  2013-06-26       Impact factor: 16.971

9.  Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.

Authors:  N M Archin; A L Liberty; A D Kashuba; S K Choudhary; J D Kuruc; A M Crooks; D C Parker; E M Anderson; M F Kearney; M C Strain; D D Richman; M G Hudgens; R J Bosch; J M Coffin; J J Eron; D J Hazuda; D M Margolis
Journal:  Nature       Date:  2012-07-25       Impact factor: 49.962

10.  Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing.

Authors:  Rafal Kaminski; Yilan Chen; Tracy Fischer; Ellen Tedaldi; Alessandro Napoli; Yonggang Zhang; Jonathan Karn; Wenhui Hu; Kamel Khalili
Journal:  Sci Rep       Date:  2016-03-04       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.